Azole-resistant Candida spp. - emerging pathogens?

Risk Factors for Fluconazole-Resistant Candidemia

(2010) J. Garnacho-Montero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

(2010) D. A. Oxman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death

(2010) M. A. Slavin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Epidemiology of Candida Colonization and Invasive Candidiasis in a Surgical Intensive Care Unit Where Fluconazole Prophylaxis is Utilized

(2009) Shelley S. Magill et al.   ANNALS OF SURGERY

Avian Aspergillus fumigatus Strains Resistant to both Itraconazole and Voriconazole

(2009) L. A. Beernaert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Anidulafungin MICs Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) and Etest for Candida Species Isolates

(2009) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections

(2009) Ingi Lee et al.   ARCHIVES OF INTERNAL MEDICINE

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance inCandida albicans

(2009) Adnane Sellam et al.   EUKARYOTIC CELL

Identification of theCandida albicansCap1p Regulon

(2009) Sadri Znaidi et al.   EUKARYOTIC CELL

Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans

(2009) Chia-Geun Chen et al.   FUNGAL GENETICS AND BIOLOGY

Regulation of multidrug resistance in pathogenic fungi

(2009) Joachim Morschhäuser   FUNGAL GENETICS AND BIOLOGY

Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

(2009) Sélène Ferrari et al.   PLoS Pathogens

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

(2008) J. W. Baddley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains

(2008) S. Schubert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The changing epidemiology of invasive candidiasis

(2008) Ray Hachem et al.   CANCER

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

(2008) J.L. Rodriguez-Tudela et al.   CLINICAL MICROBIOLOGY AND INFECTION

A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a ClinicalCandida albicansIsolate

(2008) Nico Dunkel et al.   EUKARYOTIC CELL